Characterization and management of serpentine supravenous reaction: a nine-patient case series
Authors:
- Katie LuKLKatie Lu
- Gabrielle ArkemaGAGabrielle Arkema
- Jarish N. CohenJCJarish N. Cohen
- Rony A. FrancoisRFRony A. Francois
- Julie Y. RamseierJRJulie Y. Ramseier
- Allison S. DobryADAllison S. Dobry
Open Access
- 9 July 2026
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 75, 243-251
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Serpentine Supravenous Hyperpigmentation, a Phenomenon Following the Administration of Chemotherapeutic Agents: A Systematic ReviewHealth Science Reports, 2024
- Serpentine supravenous hyperpigmentation induced by chemotherapy: a systematic reviewArchives of Dermatological Research, 2024
- Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2017
- Dermatologic Toxicity of Chemotherapeutic AgentsSeminars in Oncology, 2006
- Serpentine Supravenous Fluorouracil HyperpigmentationJAMA, 1976